# An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures

> **NCT02783404** · PHASE4 · TERMINATED · sponsor: **University of Santiago de Compostela** · enrollment: 40 (actual)

## Conditions studied

- Bacteraemia
- Endocarditis

## Interventions

- **DRUG:** Amoxicillin
- **DRUG:** Amoxicillin-Potassium Clavulanate

## Key facts

- **NCT ID:** NCT02783404
- **Lead sponsor:** University of Santiago de Compostela
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-27
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-05-17
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Significant results (no control neither amoxicillin new arms needed)
- **Last updated:** 2022-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02783404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02783404, "An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02783404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*